Combined Tests Based on Restricted Mean Time Lost for Competing Risks Data

被引:2
作者
Lyu, Jingjing [1 ]
Hou, Yawen [2 ]
Chen, Zheng [1 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangdong Prov Key Lab Trop Dis Res, 1023 South Shatai Rd, Guangzhou 510515, Peoples R China
[2] Jinan Univ, Sch Econ, Dept Stat, Guangzhou 510632, Peoples R China
基金
中国国家自然科学基金;
关键词
Combined test; Competing risks; Nonproportional subdistribution hazards; Restricted mean time lost; SURVIVAL-TIME; CUMULATIVE INCIDENCE; LIFE; TRIALS;
D O I
10.1080/19466315.2021.1994456
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Competing risks data are common in medical studies, and the sub-distribution hazard (SDH) ratio is considered an appropriate measure. However, because the limitations of hazard itself are not easy to interpret clinically and because the SDH ratio is valid only under the proportional SDH assumption, this article introduced an alternative index under competing risks, named restricted mean time lost (RMTL). Several test procedures were also constructed based on RMTL. First, we introduced the definition and estimation of RMTL based on Aalen-Johansen cumulative incidence functions. Then, we considered several combined tests based on the SDH and the RMTL difference (RMTLd). The statistical properties of the methods are evaluated using simulations and are applied to two examples. The Type I errors of combined tests are close to the nominal level. All combined tests show acceptable power in all situations. In conclusion, RMTL can meaningfully summarize treatment effects for clinical decision making, and three combined tests have robust power under various conditions, which can be considered for statistical inference in real data analysis.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 31 条
[1]   Decomposition of number of life years lost according to causes of death [J].
Andersen, P. K. .
STATISTICS IN MEDICINE, 2013, 32 (30) :5278-5285
[2]  
Andersen P.K., 1993, STAT MODELS BASED CO
[3]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[4]   An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use [J].
Calkins, Keri L. ;
Canan, Chelsea E. ;
Moore, Richard D. ;
Lesko, Catherine R. ;
Lau, Bryan .
BMC MEDICAL RESEARCH METHODOLOGY, 2018, 18
[5]   Statistical inference methods for cumulative incidence function curves at a fixed point in time [J].
Chen, Jinbao ;
Hou, Yawen ;
Chen, Zheng .
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2020, 49 (01) :79-94
[6]   Cumulative incidence estimation in the presence of competing risks [J].
Coviello, Vincenzo ;
Boggess, May .
STATA JOURNAL, 2004, 4 (02) :103-112
[7]   The potential for increased power from combining P-values testing the same hypothesis [J].
Ganju, Jitendra ;
Ma, Guoguang .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (01) :64-74
[8]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[9]   Sample size for a noninferiority clinical trial with time-to-event data in the presence of competing risks [J].
Han, Dong ;
Chen, Zheng ;
Hou, Yawen .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (04) :797-807
[10]   Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point [J].
Huang, Bo ;
Kuan, Pei-Fen .
PHARMACEUTICAL STATISTICS, 2018, 17 (03) :202-213